Correction: "Nuclear GIT2 Is an ATM substrate and promotes DNA repair" [Molecular and Cellular Biology, 35, 7, (1081-1096), (2015)] Doi: 10.1128/MCB.01432-14;Nuclear GIT2 Is an ATM substrate and promotes DNA repair

Molecular and Cellular Biology

Volumn 35, Issue 7, 2015, Pages 1081-1096

  Lu, Daoyuan ^a   Cai, Huan ^a   Park, Sung Soo ^a   Siddiqui, Sana ^a   Premont, Richard T ^c   Schmalzigaug, Robert ^c   Paramasivam, Manikandan ^a   Seidman, Michael ^a   Bodogai, Ionoa ^a   Biragyn, Arya ^a   Daimon, Caitlin M ^a   Martin, Bronwen ^a   Maudsley, Stuart ^a,b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; DNA; DOUBLE STRANDED DNA; G PROTEIN COUPLED RECEPTOR KINASE; G PROTEIN COUPLED RECEPTOR KINASE INTERACTING PROTEIN 2; HIGH MOBILITY GROUP N1 PROTEIN; HISTONE H2AX; MDC1 PROTEIN; MRE11 PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN; RNF8 PROTEIN; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; GIT2 PROTEIN, HUMAN; GIT2 PROTEIN, MOUSE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PHOSPHOPROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; ANIMAL; CELL LINE; CELL NUCLEUS; GENETICS; KNOCKOUT MOUSE; METABOLISM; SITE DIRECTED MUTAGENESIS; TUMOR CELL LINE;

MUS;

ANIMALS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL CYCLE PROTEINS; CELL LINE; CELL LINE, TUMOR; CELL NUCLEUS; DNA DAMAGE; DNA REPAIR; GTPASE-ACTIVATING PROTEINS; MICE; MICE, KNOCKOUT; MUTAGENESIS, SITE-DIRECTED; PHOSPHOPROTEINS;

EID: 84924853242     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00310-17     Document Type: Erratum

References (55)

1. Frappart PO, McKinnon PJ. 2006. Ataxia-telangiectasia and related diseases. Neuromolecular Med 8:495-511. http://dx.doi.org/10.1385/NMM:8:4:495.
2. Madabhushi R, Pan L, Tsai LH. 2014. DNA damage and its links to neurodegeneration. Neuron 83:266-282. http://dx.doi.org/10.1016/j.neuron.2014.06.034.
3. McKinnon PJ. 2004. ATM and ataxia telangiectasia. EMBO Rep 5:772-776. http://dx.doi.org/10.1038/sj.embor.7400210.
4. Perlman S, Becker-Catania S, Gatti RA. 2003. Ataxia-telangiectasia: diagnosis and treatment. Semin Pediatr Neurol 10:173-182. http://dx.doi.org/10.1016/S1071-9091(03)00026-3.
5. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NG, Taylor AM, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y. 1995. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753. http://dx.doi.org/10.1126/science.7792600.
6. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y. 1998. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674-1677. http://dx.doi.org/10.1126/science.281.5383.1674.
7. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD. 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677-1679. http://dx.doi.org/10.1126/science.281.5383.1677.
8. Falck J, Coates J, Jackson SP. 2005. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites ofDNAdamage. Nature 434:605-611. http://dx.doi.org/10.1038/nature03442.
9. Lee JH, Paull TT. 2004. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science 304:93-96. http://dx.doi.org/10.1126/science.1091496.
10. Lim DS, Kim ST, Xu B, Maser RS, Lin J, Petrini JH, Kastan MB. 2000. ATMphosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 404:613-617. http://dx.doi.org/10.1038/35007091.
11. Wu X, Ranganathan V, Weisman DS, Heine WF, Ciccone DN, O'Neill TB, Crick KE, Pierce KA, Lane WS, Rathbun G, Livingston DM, Weaver DT. 2000. ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature 405:477-482. http://dx.doi.org/10.1038/35013089.
12. Gatei M, Sloper K, Sorensen C, Syljuasen R, Falck J, Hobson K, Savage K, Lukas J, Zhou BB, Bartek J, Khanna KK. 2003. Ataxia-telangiectasiamutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation. J Biol Chem 278:14806-14811. http://dx.doi.org/10.1074/jbc. M210862200.
13. Matsuoka S, Rotman G, Ogawa A, Shiloh Y, Tamai K, Elledge SJ. 2000. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci USA 97:10389-10394. http://dx.doi.org/10.1073/pnas.190030497.
14. Xu B, O'Donnell AH, Kim ST, Kastan MB. 2002. Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation. Cancer Res 62:4588-4591.
15. Kitagawa R, Bakkenist CJ, McKinnon PJ, Kastan MB. 2004. Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway. Genes Dev 18:1423-1438. http://dx.doi.org/10.1101/gad.1200304.
16. Kamer I, Sarig R, Zaltsman Y, Niv H, Oberkovitz G, Regev L, Haimovich G, Lerenthal Y, Marcellus RC, Gross A. 2005. Proapoptotic BID is an ATM effector in the DNA-damage response. Cell 122:593-603. http://dx.doi.org/10.1016/j.cell.2005.06.014.
17. Sobeck A, Stone S, Landais I, de Graaf B, Hoatlin ME. 2009. The Fanconi anemia protein FANCM is controlled by FANCD2 and the ATR/ATM pathways. J Biol Chem 284:25560-25568. http://dx.doi.org/10.1074/jbc. M109.007690.
18. Wang H, Wang M, Bocker W, Iliakis G. 2005. Complex H2AX phosphorylation patterns by multiple kinases including ATM and DNA-PK in human cells exposed to ionizing radiation and treated with kinase inhibitors. J Cell Physiol 202:492-502. http://dx.doi.org/10.1002/jcp.20141.
19. Hoefen RJ, Berk BC. 2006. The multifunctional GIT family of proteins. J Cell Sci 119:1469-1475. http://dx.doi.org/10.1242/jcs.02925.
20. Premont RT, Claing A, Vitale N, Freeman JL, Pitcher JA, Patton WA, Moss J, Vaughan M, Lefkowitz RJ. 1998. ß2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein. Proc Natl Acad Sci U S A 95:14082-14087. http://dx.doi.org/10.1073/pnas.95.24.14082.
21. Premont RT, Claing A, Vitale N, Perry SJ, Lefkowitz RJ. 2000. The GIT family of ADP-ribosylation factor GTPase-activating proteins. Functional diversity of GIT2 through alternative splicing. J Biol Chem 275:22373-22380. http://dx.doi.org/10.1074/jbc.275.29.22373.
22. Manabe R, Kovalenko M, Webb DJ, Horwitz AR. 2002. GIT1 functions in a motile, multi-molecular signaling complex that regulates protrusive activity and cell migration. J Cell Sci 115:1497-1510.
23. Zhao ZS, Manser E, Loo TH, Lim L. 2000. Coupling of PAK-interacting exchange factor PIX to GIT1 promotes focal complex disassembly. Mol Cell Biol 20:6354-6363. http://dx.doi.org/10.1128/MCB.20.17.6354-6363.2000.
24. Frank SR, Adelstein MR, Hansen SH. 2006. GIT2 represses Crk- and Rac1-regulated cell spreading and Cdc42-mediated focal adhesion turnover. EMBO J 25:1848-1859. http://dx.doi.org/10.1038/sj.emboj.7601092.
25. Phee H, Dzhagalov I, Mollenauer M, Wang Y, Irvine DJ, Robey E, Weiss A. 2010. Regulation of thymocyte positive selection and motility by GIT2. Nat Immunol 11:503-511. http://dx.doi.org/10.1038/ni.1868.
26. Mazaki Y, Hashimoto S, Tsujimura T, Morishige M, Hashimoto A, Aritake K, Yamada A, Nam JM, Kiyonari H, Nakao K, Sabe H. 2006. Neutrophil direction sensing and superoxide production linked by the GTPase-activating protein GIT2. Nat Immunol 7:724-731. http://dx.doi.org/10.1038/ni1349.
27. Zhang H, Webb DJ, Asmussen H, Horwitz AF. 2003. Synapse formation is regulated by the signaling adaptor GIT1. J Cell Biol 161:131-142. http://dx.doi.org/10.1083/jcb.200211002.
28. Zhang H, Webb DJ, Asmussen H, Niu S, Horwitz AF. 2005. A GIT1/PIX/Rac/PAK signaling module regulates spine morphogenesis and synapse formation through MLC. J Neurosci 25:3379-3388. http://dx.doi.org/10.1523/JNEUROSCI.3553-04.2005.
29. Ko J, Kim S, Valtschanoff JG, Shin H, Lee JR, Sheng M, Premont RT, Weinberg RJ, Kim E. 2003. Interaction between liprin-alpha and GIT1 is required for AMPA receptor targeting. J Neurosci 23:1667-1677.
30. Segura I, Essmann CL, Weinges S, Acker-Palmer A. 2007. Grb4 and GIT1 transduce ephrinB reverse signals modulating spine morphogenesis and synapse formation. Nat Neurosci 10:301-310. http://dx.doi.org/10.1038/nn1858.
31. Schmalzigaug R, Phee H, Davidson CE, Weiss A, Premont RT. 2007. Differential expression of the ARF GAP genes GIT1 and GIT2 in mouse tissues. J Histochem Cytochem 55:1039-1048. http://dx.doi.org/10.1369/jhc.7A7207.2007.
32. Chadwick W, Zhou Y, Park SS, Wang L, Mitchell N, Stone MD, Becker KG, Martin B, Maudsley S. 2010. Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses. PLoS One 5:e14352. http://dx.doi.org/10.1371/journal.pone.0014352.
33. Chadwick W, Martin B, Chapter MC, Park SS, Wang L, Daimon CM, Brenneman R, Maudsley S. 2012. GIT2 acts as a potential keystone protein in functional hypothalamic networks associated with age-related phenotypic changes in rats. PLoS One 7:e36975. http://dx.doi.org/10.1371/journal.pone.0036975.
34. Chadwick W, Mitchell N, Caroll J, Zhou Y, Park SS, Wang L, Becker KG, Zhang Y, Lehrmann E, Wood WH, III, Martin B, Maudsley S. 2011. Amitriptyline-mediated cognitive enhancement in aged 3×Tg Alzheimer's disease mice is associated with neurogenesis and neurotrophic activity. PLoS One 6:e21660. http://dx.doi.org/10.1371/journal.pone.0021660.
35. Caffrey DR, Zhao J, Song Z, Schaffer ME, Haney SA, Subramanian RR, Seymour AB, Hughes JD. 2011. siRNA off-target effects can be reduced at concentrations that match their individual potency. PLoS One 6:e21503. http://dx.doi.org/10.1371/journal.pone.0021503.
36. Gerlitz G. 2010. HMGNs, DNA repair and cancer. Biochim Biophys Acta 1799:80-85. http://dx.doi.org/10.1016/j.bbagrm.2009.10.007.
37. Kim ST, Lim DS, Canman CE, Kastan MB. 1999. Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem 274:37538-37543. http://dx.doi.org/10.1074/jbc.274.53.37538.
38. Kitagawa R, Kastan MB. 2005. The ATM-dependent DNA damage signaling pathway. Cold Spring Harbor Symp Quant Biol 70:99-109. http://dx.doi.org/10.1101/sqb.2005.70.002.
39. Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt DW, Lee A, Bonner RF, Bonner WM, Nussenzweig A. 2003. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat Cell Biol 5:675-679. http://dx.doi.org/10.1038/ncb1004.
40. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. 2000. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 10:886-895. http://dx.doi.org/10.1016/S0960-9822(00)00610-2.
41. Peng Z, Liao Z, Dziegielewska B, Matsumoto Y, Thomas S, Wan Y, Yang A, Tomkinson AE. 2012. Phosphorylation of serine 51 regulates the interaction of human DNA ligase I with replication factor C and its participation in DNA replication and repair. J Biol Chem 287:36711-36719. http://dx.doi.org/10.1074/jbc. M112.383570.
42. Blagosklonny MV, Iglesias A, Zhan Z, Fojo T. 1998. Like p53, the proliferation-associated protein p120 accumulates in human cancer cells following exposure to anticancer drugs. Biochem Biophys Res Commun 244:368-373. http://dx.doi.org/10.1006/bbrc.1998.8278.
43. Yabe D, Fukuda H, Aoki M, Yamada S, Takebayashi S, Shinkura R, Yamamoto N, Honjo T. 2007. Generation of a conditional knockout allele for mammalian Spen protein Mint/SHARP. Genesis 45:300-306. http://dx.doi.org/10.1002/dvg.20296.
44. Daley JM, Sung P. 2014. 53BP1, BRCA1, and the choice between recombination and end joining at DNA double-strand breaks. Mol Cell Biol 34:1380-1388. http://dx.doi.org/10.1128/MCB.01639-13.
45. Stewart GS, Wang B, Bignell CR, Taylor AM, Elledge SJ. 2003. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 421:961-966. http://dx.doi.org/10.1038/nature01446.
46. Hassa PO, Haenni SS, Elser M, Hottiger MO. 2006. Nuclear ADPribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev 70:789-829. http://dx.doi.org/10.1128/MMBR.00040-05.
47. Potaman VN, Shlyakhtenko LS, Oussatcheva EA, Lyubchenko YL, Soldatenkov VA. 2005. Specific binding of poly(ADP-ribose) polymerase-1 to cruciform hairpins. J Mol Biol 348:609-615. http://dx.doi.org/10.1016/j.jmb.2005.03.010.
48. Shiloh Y. 2003. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3:155-168. http://dx.doi.org/10.1038/nrc1011.
49. Hornyik C, Terzi LC, Simpson GG. 2010. The spen family protein FPA controls alternative cleavage and polyadenylation of RNA. Dev Cell 18:203-213. http://dx.doi.org/10.1016/j.devcel.2009.12.009.
50. Fonagy A, Swiderski C, Freeman JW. 1995. Nucleolar p120 is expressed as a delayed early response gene and is inducible by DNA-damaging agents. J Cell Physiol 164:634-643. http://dx.doi.org/10.1002/jcp.1041640322.
51. Elder RM, Jayaraman A. 2012. Sequence-specific recognition of cancer drug-DNA adducts by HMGB1a repair protein. Biophys J 102:2331-2338. http://dx.doi.org/10.1016/j.bpj.2012.04.013.
52. Sareen A, Chaudhury I, Adams N, Sobeck A. 2012. Fanconi anemia proteins FANCD2 and FANCI exhibit different DNA damage responses during S-phase. Nucleic Acids Res 40:8425-8439. http://dx.doi.org/10.1093/nar/gks638.
53. Masaoka A, Gassman NR, Kedar PS, Prasad R, Hou EW, Horton JK, Bustin M, Wilson SH. 2012. HMGN1 protein regulates poly(ADP-ribose) polymerase-1 (PARP-1) self-PARylation in mouse fibroblasts. J Biol Chem 287:27648-27658. http://dx.doi.org/10.1074/jbc. M112.370759.
54. Franko J, Ashley C, Xiao W. 2001. Molecular cloning and functional characterization of two murine cDNAs which encode Ubc variants involved in DNA repair and mutagenesis. Biochim Biophys Acta 1519:70-77. http://dx.doi.org/10.1016/S0167-4781(01)00223-8.
55. Janssens J, Etienne H, Idriss S, Azmi A, Martin B, Maudsley S. 2014. Systems-level G protein-coupled receptor therapy across a neurodegenerative continuum by the GLP-1 receptor system. Front Endocrinol 5:142. http://dx.doi.org/10.3389/fendo.2014.00142.